Advances in the Detection and Monitoring of Atrial Fibrillation for Patients with Cryptogenic Ischemic Stroke.

Abstract:

:Atrial fibrillation (AF) is a significant etiologic cause of acute ischemic stroke (AIS) that leads to disabling deficits as well as significant morbidity and mortality in this population. Approximately 25 % of AIS is considered to be cryptogenic with no etiology ascertained at the time of the index event. Recent advances from the EMBRACE and CRYSTAL-AF trial have improved detection and treatment of AF and subsequently lead to changes in guidelines. However, with improved detection rates, the duration and frequency cutoffs for treating AF are currently being investigated to ensure optimization of patient selection and subsequent treatment.

journal_name

Curr Atheroscler Rep

authors

Sangha RS,Bernstein R

doi

10.1007/s11883-015-0544-3

subject

Has Abstract

pub_date

2015-12-01 00:00:00

pages

71

issue

12

eissn

1523-3804

issn

1534-6242

pii

10.1007/s11883-015-0544-3

journal_volume

17

pub_type

杂志文章,评审
  • Lifestyle factors and stroke risk: exercise, alcohol, diet, obesity, smoking, drug use, and stress.

    abstract::Various lifestyle factors have been associated with increasing the risk of stroke. These include lack of exercise, alcohol, diet, obesity, smoking, drug use, and stress. Guidelines endorsed by the Centers for Disease Control and Prevention and the National Institutes of Health recommend that Americans should exercise ...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-000-0111-3

    authors: Boden-Albala B,Sacco RL

    更新日期:2000-03-01 00:00:00

  • Lifestyle strategies for cardiovascular risk reduction.

    abstract::Daily lifestyle practices and habits profoundly affect the likelihood of developing cardiovascular disease (CVD). Abundant research and multiple recent consensus documents support the role of regular physical activity, not smoking cigarettes, maintaining a healthy body weight, controlling cholesterol levels, and contr...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-014-0444-y

    authors: Rippe JM,Angelopoulos TJ

    更新日期:2014-10-01 00:00:00

  • Obesity and Cardiovascular Disease: a Risk Factor or a Risk Marker?

    abstract::In the USA, 69 % of adults are either overweight or obese and 35 % are obese. Obesity is associated with an increased incidence of various cardiovascular disorders. Obesity is a risk marker for cardiovascular disease, in that it is associated with a much higher prevalence of comorbidities such as diabetes, hypertensio...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-016-0575-4

    authors: Mandviwala T,Khalid U,Deswal A

    更新日期:2016-05-01 00:00:00

  • A Latin American perspective on the new ACC/AHA clinical guidelines for managing atherosclerotic cardiovascular disease.

    abstract::Atherosclerotic heart disease and stroke are leading causes of disability and death worldwide, affecting not only developed countries, but also low- and middle-income regions. Different strategies for handling dyslipidemia as a critical pathogenic risk factor for atherosclerosis have been proposed. However, these reco...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-014-0400-x

    authors: Cuevas A,Arteaga A,Rigotti A

    更新日期:2014-04-01 00:00:00

  • Pharmacology of antiplatelet agents.

    abstract::Pharmacotherapies with agents that inhibit platelet function have proven to be effective in the treatment of acute coronary syndromes, and in the prevention of complications during and after percutaneous coronary intervention. Because of multiple synergetic pathways of platelet activation and their close interplay wit...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-013-0371-3

    authors: Kalra K,Franzese CJ,Gesheff MG,Lev EI,Pandya S,Bliden KP,Tantry US,Gurbel PA

    更新日期:2013-12-01 00:00:00

  • Paroxysmal Atrial Fibrillation in Cryptogenic Stroke: an Overlooked Explanation?

    abstract::Approximately one third of ischemic strokes are labeled cryptogenic because the etiology is unknown despite a thorough evaluation. Paroxysmal atrial fibrillation carries the same risk of ischemic stroke as persistent atrial fibrillation and has increasingly gained attention as a potential source of cryptogenic stroke....

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-015-0547-0

    authors: Zhang C,Kasner SE

    更新日期:2015-12-01 00:00:00

  • Perivascular Adipose Tissue and Coronary Atherosclerosis: from Biology to Imaging Phenotyping.

    abstract:PURPOSE OF REVIEW:Perivascular adipose tissue (PVAT) has a complex, bidirectional relationship with the vascular wall. In disease states, PVAT secretes pro-inflammatory adipocytokines which may contribute to atherosclerosis. Recent evidence demonstrates that pericoronary adipose tissue (PCAT) may also function as a sen...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-019-0817-3

    authors: Lin A,Dey D,Wong DTL,Nerlekar N

    更新日期:2019-11-19 00:00:00

  • Radiation-Induced Cardiovascular Disease.

    abstract:PURPOSE OF REVIEW:Thoracic radiation therapy is an effective treatment for several malignancies, such as Hodgkin's lymphoma and breast cancer. Over the years, however, the incidence of cardiovascular events has increased in these patients, notably in younger survivors who do not have traditional risk factors. This revi...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-017-0658-x

    authors: Raghunathan D,Khilji MI,Hassan SA,Yusuf SW

    更新日期:2017-05-01 00:00:00

  • Blood lipids and stroke: what more can we do besides reducing low-density lipoprotein cholesterol?

    abstract::Statin therapy has became the most important advance in stroke prevention since the introduction of aspirin and blood pressure-lowering therapies. Other lipid-modifying drugs have been less successful in reducing the incidence of stroke, but because of evidence for the use of triglyceride-lowering drugs and treatments...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-011-0186-z

    authors: Deplanque D,Amarenco P

    更新日期:2011-08-01 00:00:00

  • Patent foramen ovale and stroke: Should PFOs be closed in otherwise cryptogenic stroke?

    abstract::Since initial reports of its association with ischemic stroke appeared in 1988, there has been continued controversy regarding the existence and strength of the association between patent foramen ovale (PFO) and ischemic stroke. Many case-control studies have reported an association between incident cryptogenic ischem...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章

    doi:10.1007/s11883-010-0114-7

    authors: Carpenter DA,Ford AL,Lee JM

    更新日期:2010-07-01 00:00:00

  • The Role of Metabolic Surgery in Non-alcoholic Steatohepatitis Improvement.

    abstract:PURPOSE OF REVIEW:Non-alcoholic fatty liver disease (NAFLD) is frequently associated with obesity and overweight. It has a broad spectrum of clinical and histological presentations, such as steatosis, inflammation (known as non-alcoholic steatohepatitis or NASH), fibrosis, and cirrhosis. There is increasing evidence th...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-017-0681-y

    authors: Caravatto PP,Cohen R

    更新日期:2017-10-07 00:00:00

  • Low-density lipoprotein reduction: is the risk worth the benefit?

    abstract::Outcomes from recent lipid-lowering trials have led to an update of the third Report of the National Cholesterol Education Program (NCEP) Adult Treatment Panel's guidelines for treatment of hypercholesterolemia in adults. The updated NCEP guidelines now offer an optional goal of low-density lipoprotein (LDL) cholester...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-006-0060-6

    authors: Sabharwal AK,Boord JB

    更新日期:2006-01-01 00:00:00

  • Acute revascularization in ST-segment-elevation myocardial infarction.

    abstract::We briefly and comprehensively present some of the novel findings in the field of revascularization therapy and management of ST-segment-elevation myocardial infarction (STEMI). We highlight the latest evidence-based advancements in the pharmacological and mechanical treatment of patients who presented with STEMI. Sin...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-014-0412-6

    authors: Prodanov P,Widimsky P

    更新日期:2014-06-01 00:00:00

  • Impact of circulating esterified eicosanoids and other oxylipins on endothelial function.

    abstract::Eicosanoids, including epoxyeicosatrienoic acids, hydroxyeicosatetraenoic acids, and other oxylipins derived from polyunsaturated fatty acids, have emerging roles in endothelial inflammation and subsequent atherosclerosis. Unlike eicosanoids in the prostanoid series, they are known to be esterified in cell lipids such...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-009-0061-3

    authors: Shearer GC,Newman JW

    更新日期:2009-11-01 00:00:00

  • Soy, garlic, and ginkgo biloba: their potential role in cardiovascular disease prevention and treatment.

    abstract::There are hundreds of foods, nutrients, herbs, and botanicals that have "bioactive" constituents with potential human health benefits. Three of these are discussed in this review: soy, garlic, and ginkgo biloba. Each of these three choices involves an ingestible item composed of a complex mixture of bioactive agents. ...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-003-0037-7

    authors: Gardner CD,Messina M,Lawson LD,Farquhar JW

    更新日期:2003-11-01 00:00:00

  • Novel Anti-glycemic Drugs and Reduction of Cardiovascular Risk in Diabetes: Expectations Realized, Promises Unmet.

    abstract:PURPOSE OF REVIEW:The purpose is to review evidence on cardiovascular risks and benefits of new treatments for type 2 diabetes mellitus. RECENT FINDINGS:In response to guidance issued by the Food and Drug Administration, thousands of patients have been enrolled in large randomized trials evaluating the cardiovascular ...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-016-0633-y

    authors: Flory JH,Ukena JK,Floyd JS

    更新日期:2016-12-01 00:00:00

  • Antisense Oligonucleotides Targeting Lipoprotein(a).

    abstract:PURPOSE OF REVIEW:High lipoprotein(a) levels are observationally and causally, from human genetics, associated with increased risk of cardiovascular disease including myocardial infarction and aortic valve stenosis. The European Atherosclerosis Society recommends screening for elevated lipoprotein(a) levels in high-ris...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-019-0792-8

    authors: Langsted A,Nordestgaard BG

    更新日期:2019-05-20 00:00:00

  • The effect of gastrointestinal surgery on insulin resistance and insulin secretion.

    abstract::Diabesity is a term often used to indicate the association of type-2 diabetes mellitus (T2DM) with obesity; the prevalence of both conditions is rapidly increasing worldwide and has reached epidemic proportions. Insulin resistance represents the major determinant of T2DM, which becomes manifest once relative β-cell fa...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-012-0284-6

    authors: Castagneto M,Mingrone G

    更新日期:2012-12-01 00:00:00

  • Antiatherothrombotic effects of dipeptidyl peptidase inhibitors.

    abstract::Atherothrombotic cardiovascular events are a leading cause of morbidity and mortality in patients with type 2 diabetes (T2D). A number of factors beyond hyperglycemia contribute to this increased risk of cardiovascular events in T2D, including elevated blood pressure, dyslipidemia, inflammation, endothelial dysfunctio...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-014-0408-2

    authors: Cameron-Vendrig A,Mundil D,Husain M

    更新日期:2014-05-01 00:00:00

  • The plaque "micro" environment: microRNAs control the risk and the development of atherosclerosis.

    abstract::While the discovery of microRNAs has exponentially expanded our understanding of the regulatory mechanisms governing gene networks in many biological processes, the study of these tiny RNA powerhouses in cardiovascular disease is in its infancy. To date, there have been over 1200 human microRNAs identified, and they a...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-012-0272-x

    authors: Rayner KJ,Moore KJ

    更新日期:2012-10-01 00:00:00

  • Dietary fiber prevents carbohydrate-induced hypertriglyceridemia.

    abstract::Plant foods rich in carbohydrate and dietary fiber have many health benefits. One concern often expressed about higher carbohydrate, lower fat diets is that they may increase fasting serum triglycerides. Recently the importance of hypertriglyceridemia as an independent risk factor for coronary heart disease has been r...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-000-0055-7

    authors: Anderson JW

    更新日期:2000-11-01 00:00:00

  • Recent developments with lipoprotein-associated phospholipase A2 inhibitors.

    abstract::Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) is a calcium-independent phospholipase A(2) enzyme secreted by leukocytes and associated with circulating low-density lipoprotein and macrophages in atherosclerotic plaques. Until recently, the biological role of Lp-PLA(2) in atherosclerosis was controversial, but ...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-009-0076-9

    authors: Chauffe RJ,Wilensky RL,Mohler ER 3rd

    更新日期:2010-01-01 00:00:00

  • An Update on Gender Disparities in Coronary Heart Disease Care.

    abstract::Coronary heart disease (CHD), traditionally considered a male disease, causes far more deaths in women than cancer. The prevalence of CHD is lower in women at any age, but with advancing age, this differential decreases. The clinical outcomes including myocardial infarction mortality, all-cause mortality, and reinfarc...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-016-0574-5

    authors: Shah T,Palaskas N,Ahmed A

    更新日期:2016-05-01 00:00:00

  • Vascular pleiotropy of statins: clinical evidence and biochemical mechanisms.

    abstract::The ability of statins to lower serum cholesterol and reduce coronary heart disease endpoints has confirmed portions of the lipid hypothesis. However, the time to benefit and increased benefit in overlapping populations have suggested that nonlipid or pleiotropic effects of statins may be present. The apparent benefit...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-003-0066-2

    authors: Callahan AS 3rd

    更新日期:2003-01-01 00:00:00

  • Role of cis-Monounsaturated Fatty Acids in the Prevention of Coronary Heart Disease.

    abstract::The effects of cis-monounsaturated fatty acids (cis-MUFAs) on the risk of coronary heart disease (CHD) and on CHD mortality are not clear. Also, dietary recommendations for cis-MUFA as derived by various organizations are not in agreement. Earlier studies have mainly focused on the effects of cis-MUFA on serum lipids ...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-016-0597-y

    authors: Joris PJ,Mensink RP

    更新日期:2016-07-01 00:00:00

  • Optimal low-density lipoprotein levels: evidence from epidemiology and clinical trials.

    abstract::Aggressive lipid lowering was initially controversial due to evidence from epidemiologic studies that implied an increase in total mortality with low cholesterol levels combined with equivocal results from early trials utilizing bile acid resins or fibric acid derivatives. The advent of statin therapy allowed signific...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-006-0053-5

    authors: Todd J,Farmer JA

    更新日期:2006-03-01 00:00:00

  • Is atherosclerosis regression a realistic goal of statin therapy and what does that mean?

    abstract::Atherosclerosis is a complex disease associated with aberrant lipoprotein metabolism and leukocyte infiltration into arterial tissue that leads to cardiovascular diseases. Statins have emerged as among the most effective means of reducing the risk of cardiovascular disease in both primary and secondary prevention sett...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-012-0294-4

    authors: Singh M,Bedi US

    更新日期:2013-01-01 00:00:00

  • Novel mechanisms of abdominal aortic aneurysms.

    abstract::Abdominal aortic aneurysms (AAAs) are a common but asymptomatic disease that has high susceptibility to rupture. Current therapeutic options are limited to surgical procedures because no pharmacological approaches have been proven to decrease either expansion or rupture of human AAAs. The current dearth of effective m...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-012-0271-y

    authors: Lu H,Rateri DL,Bruemmer D,Cassis LA,Daugherty A

    更新日期:2012-10-01 00:00:00

  • Computerized approaches to communication retraining after stroke.

    abstract::Augmentative and alternative communication (AAC) strategies traditionally have been designed for individuals for whom oral speech is not a viable option. Common clinical practice has expanded AAC use to a tool for cognitive retraining or remediation. Although technologic developments offer the potential for vastly imp...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-002-0008-4

    authors: Ansel BM,Weinrich M

    更新日期:2002-07-01 00:00:00

  • Should hyperhomocysteinemia be treated in patients with atherosclerotic disease?

    abstract::Numerous retrospective and prospective observational studies support an association between elevated homocysteine and increased risk for myocardial infarction, stroke, and peripheral vascular disease. Although folic acid therapy substantially reduces homocysteine levels, recent large, randomized controlled trials fail...

    journal_title:Current atherosclerosis reports

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/s11883-007-0048-x

    authors: Maron BA,Loscalzo J

    更新日期:2007-11-01 00:00:00